Exposure in vivo or in vitro to elevated glucose increases production of vasoactive prostaglandins by glomeruli and mesangial cells. This study aimed to determine whether this increased prostaglandin production could provide a link with later structural changes in diabetic nephropathy. Glomerular cores were prepared from control rats and streptozotocin-diabetic rats (3 weeks' duration). Over 24 h in culture hyaluronan production from diabetic glomerular cores was higher than production from control glomerular cores whether maintained in 5.6 mmol/l glucose (105.6 + 15.5 vs 53.6 + 8.5 ng hyaluronan per 250 glomerular cores, p <0.001); in 25 mmol/1 glucose (149.3 + 34.8 vs 62.7 + 7.8 ng hyaluronan per 250 glomerular cores, p < 0.01); or in 45 mmol/1 glucose (176.8 + 23.3 vs 102.0 + 17.9 ng hyaluronan per 250 glomerular cores, p < 0.01). At 5.6 mmol/1 glucose, exposure in vitro to prostaglandin Ez caused an increase in hyaluronan production [maximal at 10 -9 mol/1 prostaglandin E 2, 237 + 19 vs 42+4, ng hyaluronan per 250 glomerular cores, p < 0.001 (control) and 195 + 7 vs 103 + 5, ng hyaluronan per 250 glomerular cores, p < 0.001 (diabetic) ]. In both control and diabetic glomerular cores hyaluronan production was reduced significantly by the cyclooxygenase inhibitor indomethacin (10-5mol/1) [24.7 + 3.33 vs 40.25 + 4.11 ng hyaluronan per 250 glomerular cores, p < 0.05 (control) and 36.5 + 6.25 vs 118.0 + 22.6, p < 0.01 (diabetic)]. A direct spectrophotometric microassay was used to determine the concentration of sulphated glycosaminoglycans derived from papain-digested glomerular core proteoglycans. Release of sulphated glycosaminoglycans from diabetic glomerular cores maintained at 5.6 mmol/1 glucose was decreased [41.9 + 1.1 vs 54.0 + 1.0 ~g of sulphated glycosaminoglycans (chondroitin sulphate) per 250 glomerular cores p < 0.01]. A decrease in sulphated glycosaminoglycans was also shown from control glomerular cores maintained at 25 mmol/1 glucose. At this glucose concentration, addition of exogenous hyaluronan or prostaglandin E 2 significantly reduced sulphated glycosaminoglycans from control and diabetic glomerular cores. It is concluded that increased prostaglandin production secondary to high glucose environment can lead to an increased glomerular hyaluronan synthesis. This can substantially affect the levels of sulphated glycosaminoglycans in the extracellular matrix. We propose that these effects provide a possible link between the initial biochemical consequences of hyperglycaemia and later structural changes seen in the glomerulus in diabetes. [Diabetologia (1995) 38:298-3051 
Summary
Exposure in vivo or in vitro to elevated glucose increases production of vasoactive prostaglandins by glomeruli and mesangial cells. This study aimed to determine whether this increased prostaglandin production could provide a link with later structural changes in diabetic nephropathy. Glomerular cores were prepared from control rats and streptozotocin-diabetic rats (3 weeks' duration). Over 24 h in culture hyaluronan production from diabetic glomerular cores was higher than production from control glomerular cores whether maintained in 5.6 mmol/l glucose (105.6 + 15.5 vs 53.6 + 8.5 ng hyaluronan per 250 glomerular cores, p <0.001); in 25 mmol/1 glucose (149.3 + 34.8 vs 62.7 + 7.8 ng hyaluronan per 250 glomerular cores, p < 0.01); or in 45 mmol/1 glucose (176.8 + 23.3 vs 102.0 + 17.9 ng hyaluronan per 250 glomerular cores, p < 0.01). At 5.6 mmol/1 glucose, exposure in vitro to prostaglandin Ez caused an increase in hyaluronan production [maximal at 10 -9 mol/1 prostaglandin E 2, 237 + 19 vs 42+4, ng hyaluronan per 250 glomerular cores, p < 0.001 (control) and 195 + 7 vs 103 + 5, ng hyaluronan per 250 glomerular cores, p < 0.001 (diabetic) ]. In both control and diabetic glomerular cores hyaluronan production was reduced significantly by the cyclooxygenase inhibitor indomethacin (10-5mol/1) [24.7 + 3.33 vs 40.25 + 4.11 ng hyaluronan per 250 glomerular cores, p < 0.05 (control) and 36.5 + 6.25 vs 118.0 + 22.6, p < 0.01 (diabetic)]. A direct spectrophotometric microassay was used to determine the concentration of sulphated glycosaminoglycans derived from papain-digested glomerular core proteoglycans. Release of sulphated glycosaminoglycans from diabetic glomerular cores maintained at 5.6 mmol/1 glucose was decreased [41.9 + 1.1 vs 54.0 + 1.0 ~g of sulphated glycosaminoglycans (chondroitin sulphate) per 250 glomerular cores p < 0.01]. A decrease in sulphated glycosaminoglycans was also shown from control glomerular cores maintained at 25 mmol/1 glucose. At this glucose concentration, addition of exogenous hyaluronan or prostaglandin E 2 significantly reduced sulphated glycosaminoglycans from control and diabetic glomerular cores. It is concluded that increased prostaglandin production secondary to high glucose environment can lead to an increased glomerular hyaluronan synthesis. This can substantially affect the levels of sulphated glycosaminoglycans in the extracellular matrix. We propose that these effects provide a possible link between the initial biochemical consequences of hyperglycaemia and later structural changes seen in the glomerulus in diabetes. [Diabetologia (1995) 38:298-3051
An increase in glomerular and mesangial cell prostaglandin (PG) production in experimental diabetes has been demonstrated by many means [1] [2] [3] [4] . We, and others, have shown that a glucose concentrationdependent production of prostaglandin observed early in the course of experimental diabetes may arise from an increased supply of arachidonic acid following raised phospholipase A 2 activity [5] [6] [7] [8] [9] [10] [11] . Increased activity of phospholipase A2 appears to be secondary to the stimulation of protein kinase C activity following de novo diacylglycerol synthesis from glycolytic intermediates [8, [10] [11] [12] . Prostaglandins are considered to contribute to renal vasodilatory hyperfunction and hyperfiltration seen in early diabetes [3, 4, 13] . However, a possible effect of prostaglandins on the structure of glomeruli, including modification of extracellular matrices and, in particular, a reduction in the content of sulphated proteoglycans has not been examined. Reduction of sulphated proteoglycans is believed to contribute to loss of renal charge and selective permeability in the glomerulus [14] [15] [16] [17] [18] [19] . Studies in other tissues have shown that the synthesis of hyaluronan, a non-sulphated glycosaminoglycan, is increased following exposure to prostaglandins in vitro [20] [21] [22] [23] . Hyaluronan is a major matrix polysaccharide with repeating disaccharide units of glucuronic acid and n-acetylglucosamine. It is synthesised on the inner side of the plasma membrane, by the enzyme hyaluronan synthetase, and extruded directly into the extracellular space to form a poly-disperse, high molecular weight expanded coil [24] . Hyaluronan may be found as free glycosaminoglycan or as part of complex matrix proteoglycan structures and may attach to the cell surface via specific hyaluronan binding proteins [25] . By binding to specific proteins in the matrix, hyaluronan has also been shown to have a role in tissue stability and structure, being involved in tissue repair and remodelling ' [26] . In fibroblasts hyaluronan synthesis is promoted by platelet-derived growth factor (PDGF) (via the B-type PDGF receptor), epidermal growth factor, basic fibroblast growth factor and transforming growth factor/31 [27] . Hyaluronan synthetase activity, measured by the incorporation of 14C-glucuronic acid from UDp-14C-glucuronic acid into polymeric hyaluronan, is increased by serum factors, insulin-like growth factor I, various nucleotides, prostaglandin E 2 (PGE2), cyclic AMP and theophylline [20, 28] . Furthermore, hyaluronan inhibits sulphated glycosaminoglycan (GAG) synthesis and accumulation of newly synthesised proteogtycans in chondrocytes [29] [30] [31] [32] . We considered it possible that hyaluronan could provide a link between the increased synthesis of prostaglandins and the reduction of sulphated proteoglycan described in many investigations of the diabetic glomerulus. In the present study we have used a sensitive ligand-binding assay for hyaluronan [33] , which avoids the differences in specific activity of 299 precursors for hyaluronan disaccharides, which may result when techniques based on incorporation of radioactive-labelled precursors are used to assess hyaluronan synthesis at high glucose concentrations. We examined hyaluronan synthesis in g!omerular preparations in response to sustained glucose exposure and to exogenous PGE 2 in vitro and describe its increased production under these conditions and in glomerular preparations from diabetic rats. We have demonstrated a concomitant decrease in sulphated proteoglycans and propose that this may be mediated by the prostaglandin-induced increase in extracellular hyaluronan. were suspended in 0.5 ml of Dulbecco's modified Eagle's medium (DMEM) containing 5.6 retool/1 glucose and supplemented with 5 % fetal bovine serum, penicillin (100 U/ml) and streptomycin (100 ,uU/ml) and were maintained in an atmosphere of 5 % CO2 in air with additions to modify the concentration of glucose, prostaglandin E 2 and hyaluronan as shown. Where indicated, mannitol was added to compare glucose supplementation under conditions of equal osmolality. At the completion of incubations, medium was collected for determination of hyaluronan and sulphated glycosaminoglycan concentration. Glomerular core cell viability was deter-' mined by trypan blue exclusion at this time.
Materials and methods

Induction
Ligand binding assay of hyaluronan. A radiometric binding assay based on a specific hyaluronan binding protein (HABP) isolated from bovine cartilage was used to determine hyaluronan released to the culture medium by glomerular cores [33] . Preliminary experiments established that the culture medium contained 83 +_ 7 % of the hyaluronan produced by the cell and that this was unchanged by STZ-diabetes [87 +_ 8 %]. Hyaluronan was allowed to bind 125-1-1abelled HABP in solution for 60 min. Subsequently, unbound 125-I-HABP was quantitated following incubation with hyaluronan covalently coupled to sepharose and separation by centrifugation. The concentration of hyaluronan was calculated from a standard curve prepared from purified avian (rooster comb) hyaluronan [33] .
Dye-binding assay for sulphated glycosaminoglycans. Glycosaminoglycans were obtained from glomerular core preparations (culture medium and cell layer) by digestion with papain. After incubation, the medium and cell layers were separated and each was digested with papain (40U/ml) in 20 mmol/1 phosphate buffer, pH 6.8 containing 10 mmol/1 cysteine, 1 mmol/1 EDTA and 2 mmol/1 dithiothrietol at 60~ for 2 h, in order to release sulphated GAG chains from proteoglycan core proteins. Sulphated glycosaminoglycan content was assayed by a modification [36] of a direct spectrophotometric microassay [37] . This assay is based on the metachromatic shift in adsorption maximum which occurs at 590 nm when 1,9 dimethyl methylene blue complexes with sulphated glycosaminoglycans and uses purified whale chondroitin 4-sulphate as a standard sulphated GAG. Hyaluronan, which is non-sulphated is not detected with this assay technique. 
Results
Production of hyaluronan can be shown in the medium from glomerular cores maintained in culture for 24 h. When maintained for this time at 5.6 mmol/1 glucose there is a significantly increased production from glomerular cores obtained from STZ-diabetic animals (Fig. 1A ). This significant difference between control and STZ-derived GC was maintained when the glucose concentration was raised over the 24-h culture period to 25 mmol/1 or 45 mmol/1 (Fig. 1 B) . Addition of mannitol to correct to conditions of equal osmolality was without any effect on hyaluronan production over that time (data not shown).
The effect on control cultures of raising the glucose concentration from 5.6 mmol/1 to 25 mmol/1 was investigated further over time, to determine whether hyaluronan production was maintained over a continued culture. A glucose-induced increase in hyaluronan production was maintained over 96 h of culture (Fig. 2) . Over the first 24 and 48 h in culture there was an increase in the production of hyaluronan in the presence of raised glucose levels. At these times the glomerular cores are predominantly non-adherent, retaining much of the intra-glomerular association of cells. By 72 and 96 h, cells are substantially adherent and this may be causal in the marked increase in hyaluronan production seen at both 5.6 and 25 mmol/1 glucose. However, even at the elevated level of hyaluronan seen at later culture times, a significant increase in hyaluronan production is seen with raised glucose concentrations.
The effect of exogenous prostaglandin addition on hyaluronan production was investigated over 24 h in culture. The results show that hyaluronan produc- tion was significantly increased in a concentration-dependent manner following exposure of glomerular cores to PGE 2 for 24 h. At the lowest concentration tested, 10 -12 mol/1, a significant difference in hyaluronan production (p < 0.0001) was apparent in control cores (Fig. 3) . In these preparations the response to increasing PGE 2 concentrations in culture was bellshaped, with maximum effect seen at 10 -9 mol/1 301 -Indo +lndo -Indo +lndo Con STZ Fig. 4 . Effect of cyclooxygenase inhibition on hyaluronan production. Glomerular cores from control and STZ diabetic rats were incubated with indomethacin (Indo) (10 -5 mol/1) for 24 h at 5.6 mmol/l glucose and hyaluronan production determined. The values are expressed as ng of hyaluronan (HA) produced per 250 glomerular cores (mean + SEM for four experiments). Significant difference from basal production is indicated by *p < 0.01 PGE 2. A response to PGE 2 could also be shown in glomerular cores from STZ-diabetic animals (Fig. 3) . However, in comparison with control glomerular cores, the concentration response was more variable and an optimal concentration less well defined, although a significant increase was observed also at 10 .9 mol/1 PGE 2 (p < 0.0001).
In both control and STZ-derived glomerular cores hyaluronan production was inhibited significantly by the presence of the cyclooxygenase inhibitor indomethacin (10 -5 mol/1) (Fig. 4) . Significantly, the elevated production of hyaluronan from STZ-derived cores was reduced so that no difference was seen between control and STZ-derived cores in the presence of indomethacin. This finding was confirmed with two structurally dissimilar cyclooxygenase inhibitors, mefenamic acid and flufenamic acid (data not shown), suggesting that endogenous prostaglandin contributes to increased hyaluronan production.
The concentration of sulphated glycosaminoglycans derived from papain-digested glomerular core proteoglycans was determined. In an initial series of four experiments performed at 5.6 mmol/1 glucose, total sulphated glycosaminoglycan production (glomerular cells + medium) from STZ-D glomerular cores was significantly reduced when compared to control (53.1 _+ 4.1 vs 70.3 + 5.0 ~tg chondroitin sup phate per 250 glomerular cores, p < 0.05). In these experiments it was shown further that the sulphated glycosaminoglycans from proteoglycans released into the medium by control glomerular cores was 82 _+ 2 % of total sulphated glycosaminoglycans and that from STZ-D glomerular cores was 86 + 3 % (NS) and in subsequent experiments the concentration of glycosaminoglycans in the culture medium following incubations with and without supplemented glucose, hyaluronan or PGE 2 was determined. Sulphated glycosaminoglycans present in the medium, from glomerular cores maintained for 24 h in culture at 5.6 and 25 mmol/1 glucose are shown in Figure 5 . The concentration was decreased in STZ-derived glomerular cores at both 5.6 and 25 mmol/1 glucose. Further, at both glucose concentrations, addition of hyaluronan, 250 ng/ml as a high molecular weight polymer of 5 x 106 Da, decreased sulphated glycosaminoglycan levels significantly in both control and STZ-derived glomerular cores (Fig.5 ). When cultured with PGE 2 (10 -9 mol/1) at 25 mmol/1 glucose, there was a significant reduction in sulphat- 
Discussion
This study demonstrates that STZ-diabetic rats have increased production of hyaluronan from glomerular cores which are rich in mesangial cells. We have shown that exposure of glomerular cores to high glucose stimulates hyaluronan production. Two potential mechanisms can be postulated for the glucose-mediated increase in hyaluronan synthesis. Glucose may increase the UDP-precursor pools, providing more UDP-n-acetylglucosamine and UDP-glucuronic acid, for hyaluronan production. Diabetes may additionally modify this utilisation of glucose via augmentation of the pentose phosphate pathway [38] , enhancing this effect. Alternatively, glucose may mediate increased hyaluronan synthesis by the cellular pathway in which increased de novo synthesis of diacylglycerol from glucose-derived trioses provides a mechanism for protein kinase C-dependent activation of phospholipase A; with increased production of cellular arachidonic acid and subsequent to this an increased prostaglandin production [12] . The diabetic glomerulus has been shown consistently to have increased prostaglandin production [1] [2] [3] [4] [5] . The present study demonstrates that exogenous PGE 2 stimulates hyaluronan synthesis by glomerular cores. Exogenous prostaglandins have been shown to potentiate hyaturonan synthesis in other cell culture systems, including human synovial cells [22] , rat fibroblasts [20] and rabbit pericardial cells [23] . In these latter cells, Honda and co-workers [23] have shown that a cyclic AMP-dependent protein kinase A-mediated phosphorylation is involved in increased hyaluronan production. In that study exogenous arachidonic acid stimulated hyaluronan synthesis, supporting a link between prostaglandin production and cyclic AMP-mediated hyaluronan production. As with studies in other cell types [22, 39] , the inhibitory effect of indomethacin on hyaluronan in the present study confirms the involvement of endogenous prostaglandin synthesis.
In various tissues or cell culture systems stimulation of hyaluronan synthesis may be induced by fetal bovine serum [20] 44] , or polyinosine and polycytidine inducers of interferon [22] . Thus, multiple signalling pathways may contribute to stimulation of endogenous hyaluronan synthesis. These may be interrelated and also determined by cell type. Recently it has been reported that both tyrosine phosphorylation and protein kinase C-dependent events are involved in the stimulation of hyaluronan synthetase activity by PDGF-BB in human mesothelial cells [44] . A bacterial hyaluronan synthetase enzyme has recently been cloned and sequenced and shown to have a potential tyrosine kinase phosphorylation site [45] . However, the molecular mechanism(s) for stimulation of hyaluronan synthesis are not currently known.
Recent studies of macrovascular disease in diabetes have shown that hyaluronan may play a role in generalised diabetic angiopathy. Accumulation of hyaluronan has been reported by Heickendorff et al. [46] in the tunica media of the aorta of diabetic patients and suggests a role for hyaluronan associated changes in the extracellular matrix of the arterial wall. A role in microvascular complications has not been considered previously. In the diabetic kidney much of the previous work on proteoglycan content has focussed on the heparan sulphate proteoglycans (HSPG) of the basement membrane in which decreased staining for HSPG [47, 48] and decreased sulphate incorporation into HSPG of basement membrane [15, 16] have been demonstrated in vitro in glomeruli isolated from diabetic rats. This is thought to give rise to a decreased sulphate: uronate ratio in heparan sulphate proteoglycans of glomerular basement membrane isolated from diabetic rats. Elevated glucose concentrations have been shown to decrease the content of basement membrane-associated heparan sulphate in proliferating cultured porcine mesangial cells [19] . An inhibitory effect of hyperglycaemic glucose concentrations on human mesangial cell proteoglycan synthesis was demonstrated by Mason et al. [49] . This is in contrast to a stimulatory effect of diabetes or of raised glucose concentration on the production of other matrix macromolecules in the glomerulus and mesangial cells. We have shown in the present investigation that mesangial cell enriched glomerular cores derived from STZ-diabetic animals have a significant decrease in sulphated glycosaminoglycans.
There is limited information regarding the quantity and character of the proteoglycans of the mesangial matrix. Chondroitin sulphate and dermatan sulphate are present in the mesangial matrix and chondroitin sulphate has been shown to be the major glycosaminoglycan found in proteoglycans localized to the mesangium and is not present in any significant amount in the glomerular basement membrane [49] . Proteoglycans have been shown to interact specifically with other components in the extracellular matrix, such as collagen, fibronectin other proteoglycans, growth factors and cells [50] . These interactions are mediated partly via the negatively charged glycosaminoglycan chains of the proteoglycans, and affect cell binding to matrix and cell proliferation [51] [52] [53] [54] [55] [56] . Silbiger et al. [57] have demonstrated that mesangial cells cultured in high glucose produce proteoglycans with a lower negative charge density and have further suggested that this is related to decreased sulphation of the glycosaminoglycan component of proteoglycans.
We have demonstrated in the present study that the presence of hyaluronan significantly reduces sulphated glycosaminoglycans in glomerular cores and have identified a mechanism whereby hyaluronan may be raised in cells exposed to high glucose or in diabetes. The mechanism for the inhibitory action of hyaluronan on sulphated glycosaminoglycans' has been investigated in various cell culture models [29] [30] [31] [32] Measurements of PGE 2 production by isolated rat glomeruli [61, 62] or the production of PGE 2 from individual glomeruli in vivo by micropuncture [63] show a basal production of between 0.57 and 2.2 fmol per glomeruli over 10 min. In the latter study measurement of single nephron glomerular filtration rate in the earliest proximal convolution allows an estimation of glomerular PGE 2 concentration in the nanomolar range. Thus, the concentrations of PGE 2 found to be effective in the present study are of physiological relevance. The present study shows that elevated prostaglandin production, considered previously to be associated with an early functional effect on vasodilatation and hyperfiltration in diabetes, may also affect the mesangial matrix organization. Specifically, the changes may promote a mesangial matrix with reduced content of sulphated glycosaminoglycans in which interactions with other matrix components are altered [53] [54] [55] [56] 59 ]. The present findings were obtained under diabetic conditions modelled in vitro, and although caution must be exercised in extrapolating to the long-term in vivo situation, they provide a potential link between the biochemical consequences of hyperglycaemia and matrix structural changes seen in the later stages of diabetic nephropathy. 
